StockData
Cellectar Biosciences, Inc. logo

Cellectar Biosciences, Inc. (CLRB) stock

CLRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$0.89−0.04 (-3.81%)

Close on Nov 18, 2026Market cap $8.37MP/E –Yield –

Cellectar Biosciences pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Cellectar Biosciences's pe ratio was 1.5× on Jan 31, 2017.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2017Jan 31, 20171.5×+0.4
2016Dec 30, 20161.1×–

More Cellectar Biosciences figures

See a number that looks wrong?